Goldman Sachs Group Inc - Dec 23, 2022 Form 3 Insider Report for Rosecliff Acquisition Corp I (MDAI)

Role
10%+ Owner
Signature
/s/ Jamison Yardley, Attorney-in-fact
Stock symbol
MDAI
Transactions as of
Dec 23, 2022
Transactions value $
$0
Form type
3
Date filed
2/10/2023, 07:46 PM
Previous filing
Dec 30, 2022
Next filing
Feb 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDAI Warrant Dec 23, 2022 Class A Common Stock 341K See Footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each warrant of Rosecliff Acquisition Corp I. (the "Issuer") entitles the holder to purchase one share of Class A ordinary shares at $11.50. The warrants become exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months from the closing of the IPO and expire five years after the completion of the initial Business Combination.
F2 This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group") and Goldman Sachs & Co. LLC ("Goldman Sachs" and together with GS Group, the "Reporting Persons"). Goldman Sachs is a subsidiary of GS Group. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. On December 23, 2022, the Reporting Persons experienced an increase in their beneficial ownership of Rosecliff Acquisition Corp. I (the "Issuer") to above 10% of the outstanding Common Stock.
F3 The securities of the Issuer reported herein as indirectly purchased were beneficially owned directly by Goldman Sachs and indirectly by GS Group.